FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

WP: VaxGen's vaccine program in doubt

The Washington Post has a follow-up to the ongoing travails of VaxGen's anthrax program. The report cites sources who say that the relationship between government officials and the company has becomes so contentious that the program's future is in doubt. Under its original contract, VaxGen was to start delivering anthrax vaccine by the end of this year. New revisions has pushed that back to 2008. The Bush Administration gave VaxGen the billion-dollar program to protect 25 million people from a potential bioterror attack.

- here's The Washington Post report for more


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Bush Administration   Vaxgen   anthrax vaccine